Stock comparison
INCYTE CORP is 2.1x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($23.68 B vs $11.25 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
INCY is larger
INCYTE CORP is 2.1x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($23.68 B vs $11.25 B).
Market value leader
INCY
INCYTE CORP is 2.1x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($23.68 B vs $11.25 B).
Revenue leader
INCY
CRL: $4.02B vs INCY: $5.14B.
Profit leader
INCY
CRL: -$144.34M vs INCY: $1.29B.
Margin leader
INCY
CRL: -3.6% vs INCY: 25.0% net margin.
| Metric | CRL | INCY |
|---|---|---|
| Market cap | $11.25 B | $23.68 B |
| US-listed rank | #889 | #563 |
| Revenue (latest FY) | $4.02B | $5.14B |
| Net income (latest FY) | -$144.34M | $1.29B |
| Net margin | -3.6% | 25.0% |
| P/E (trailing FY) | - | 18.4x |
| SEC filings | 2,387 | 2,536 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
INCYTE CORP is 2.1x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($23.68 B vs $11.25 B).
In their latest fiscal years, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B in revenue while INCYTE CORP reported $5.14B.
Full pages: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and INCYTE CORP, or browse the full rankings.